169167 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
ENTERICALLY DELIVERED BITTER OLIGOPEPTIDES FOR THE TREATMENT FOR TYPE 2 DIABETES
#2OLIGONUCLEOTIDES FOR MODULATING REGULATORY T CELL MEDIATED IMMUNOSUPPRESSION
#3OPTOGENETIC ALPHA-SYNUCLEIN AGGREGATION SYSTEM-BASED COMPOUND SCREENING PLATFORM IN PD-hiPSC-mDA NEURONS
#4SYNTHETIC RETINOIDS FOR USE IN RAR ACTIVATION
#5ASSAY AND METHODS FOR DRUG DISCOVERY
#6COMPOSITIONS AND METHODS THAT PROMOTE HYPOXIA OR THE HYPOXIA RESPONSE FOR TREATMENT AND PREVENTION OF MITOCHONDRIAL DYSFUNCTION AND OXIDATIVE STRESS DISORDERS
#7EXPRESSION SYSTEMS FOR THE ALPHA2ALPHA5BETA2 NICOTINIC ACETYLCHOLINE RECEPTOR AND METHODS OF USE THEREOF
#8EXPRESSION SYSTEMS FOR THE ALPHA6BETA4 NICOTINIC ACETYLCHOLINE RECEPTOR AND METHODS OF USE THEREOF
#9SYSTEMS, METHODS, AND COMPOSITIONS FOR PRODUCTION OF CELLULAR AGRICULTURE PRODUCTS
#10CELLS DERIVED FROM POLYPEDILUM VANDERPLANKI AND ODOR SENSOR EQUIPPED THEREWITH
#11EXPRESSION SYSTEMS FOR THE ALPHA6-CONTAINING NICOTINIC ACETYLCHOLINE RECEPTOR AND METHODS OF USE THEREOF
#12METHODS FOR IMMUNOREGULATION BY MODULATING PLASMINOGEN-APPLE-NEMATODE (PAN) DOMAIN-CONTAINING PROTEINS
#13CELLS EXPRESSING UMAMI TASTE RECEPTORS AND USES THEREOF
#14GENETICALLY ENCODED CALCIUM INDICATORS (GECIs) AND METHODS OF MAKING AND USING
#15METHODS TO DETERMINE CD4+ MEMORY T CELL RESPONSES TO SARS-COV-2 INFECTION OR VACCINATION
#16Compositions And Methods Targeting G12 Signaling For Bronchodilator Therapy
#17PROTECTION AGAINST ARTHROPOD PARASITES WITH PURINERGIC RECEPTOR (OPR) ANTAGONISTS
#18METHOD TO INVESTIGATE FUNCTION OF VOLTAGE-GATED SODIUM CHANNELS IN CELLS
#19Eyedrops for Treating Scleral Thinning and Screening Method for Therapeutic Agent of Scleral Thinning
#20METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING LYMPHOID MALIGNANCY
#21SYSTEMS, METHODS, AND COMPOSITIONS FOR PRODUCTION OF CELLULAR AGRICULTURE PRODUCTS
#22COMPOSITIONS, SYSTEMS, AND METHODS FOR DETERMINATION OF T2R AND/OR T1R PHENOTYPE IN INDIVIDUALS TO PREDICT WINE TASTING PREFERENCES, CHARACTERIZATION OF WINE IN RELATION TO INDIVIDUAL TASTING PREFERENCES, AND SELECTION OF WINE
#23IGFR-L1 ANTIBODIES AND USES THEREOF
#24MODULATION OF MAMMALIAN CELL LINEAGE BY SYNTHETIC IMMODULINS
#25Systems, methods, and compositions for production of cellular agriculture products
#26MEANS FOR CONTROLLING INTRACELLULAR REACTION UTILIZING NEEDLE-SHAPED BODY
#27Theramutein modultors
#28OLIGONUCLEIC ACID VARIANT LIBRARIES AND SYNTHESIS THEREOF
#29REPORTER CELLS EXPRESSING CHIMERIC POLYPEPTIDES FOR USE IN DETERMINING PRESENCE AND OR ACTIVITY OF IMMUNE CHECKPOINT MOLECULES
#30WNT SIGNALING AGONIST MOLECULES
#31Nucleic acids encoding peptides that block binding of a2d-1 to glutamate receptors for treating diseases and disorders
#32TESTING COLON CANCER DRUGS FOR IMMUNOMODULATORY EFFECTS
#33REGENERATION OF MAMMALIAN TISSUES USING SYNTHETIC IMMODULINS
#34METHODS OF TREATING CYSTIC FIBROSIS USING WITH-NO-LYSINE (WNK) KINASE PATHWAY INHIBITORS
#35USE OF FK506 FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
#36WNT SIGNALING AGONIST MOLECULES
#37GPCR19-P2XN RECEPTOR COMPLEX AND USE THEREOF
#38Antibodies Directed Against CD127
#39DISEASE PATHWAY-BASED METHOD TO GENERATE BIOMARKER PANELS TAILORED TO SPECIFIC THERAPEUTICS FOR INDIVIDUALIZED TREATMENTS
#40APTAMER FOR IL-21 AND USE THEREOF
#41COMPOSITIONS AND METHODS FOR TREATING G PROTEIN COUPLED RECEPTOR MEDIATED CONDITIONS
#42Method And System For Determining Intracellular Mediators' Activity
#43Method for screening personalized intestinal environment-improving material and composition therefor
#44WNT SIGNALING AGONIST MOLECULES
#45SELECTIVE PEPTIDE ANTAGONISTS
#46HIGH-SENSITIVITY DETECTION OF GPCR ACTIVITY AND USES THEREOF
#47MODULATION OF MIXED LINEAGE KINASE DOMAIN-LIKE PROTEIN SIGNALING
#48Methods for Identifying Modulators of Insect Transient Receptor Potential Channels
#49METHODS FOR QUANTIFICATION OF COMPOUNDS IN CULTIVARS OF Cannabis sp.
#50Methods of measuring signaling pathway activity for selection of therapeutic agents
#51TOOLS AND METHODS FOR EXPRESSION OF MEMBRANE PROTEINS
#52CREBBP RELATED CANCER THERAPY
#53Immodulator peptides covalently modified with small molecules
#54METHOD AND PLATFORM FOR ENHANCING DETECTION ACTIVITY OF INTERACTION BETWEEN SPIKE PROTEIN RECEPTOR BINDING DOMAIN OF CORONAVIRUS FROM SPECIMEN AND HUMAN ANGIOTENSIN-CONVERTING ENZYME II
#55APPLICATION OF NON-IGF1R-BINDING SUBSTANCE IN PREVENTION AND/OR TREATMENT OF INFLAMMATORY DISEASES
#56NOVEL APPROACH FOR INCREASING CONTRACTILITY IN PATIENTS WITH SYSTOLIC HEART FAILURE
#57METHODS AND COMPOSITIONS FOR TREATING ALZHEIMER'S DISEASE
#58NOVEL COMPOUNDS
#59Theramutein modulators
#60Genetically encoded calcium indicators (GECIs) and methods of making and using
#61Theramutein modulators
#62USE OF DKK1 INHIBITOR IN PREVENTION AND/OR TREATMENT OF TUMOR CACHEXIA AND DISEASES ASSOCIATED WITH DIABETES
#63METHOD OF TREATING ARTERIOVENOUS MALFORMATIONS BY TARGETING THE EPHRIN PATHWAY
#64Methods and compositions for diagnosing and treating, germline mismatch repair deficiencies, lynch syndrome and assessing germline risks of cancer
#65NOVEL FLAVORS, FLAVOR MODIFIERS, TASTANTS, TASTE ENHANCERS, UMAMI OR SWEET TASTANTS, AND/OR ENHANCERS AND USE THEREOF
#66FLUORESCENT PROBES FOR IDENTIFICATION AND QUANTIFICATION OF HEPATIC TRANSPORTERS IN VITRO AND IN VIVO
#67C3/C5 CONVERTASE ASSAYS
#68BIOCHEMICAL ASSAYS FOR THERAPEUTIC PROTEINS
#69METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING, GERMLINE MISMATCH REPAIR DEFICIENCIES, LYNCH SYNDROME AND ASSESSING GERMLINE RISKS OF CANCER
#70SYSTEMS AND METHODS FOR MEASURING CELL SIGNALING PROTEIN ACTIVITY
#71METHODS OF MAKING AND USING LIVER CELLS
#72GRID OF RESPONSES INDICATING DRUG SENSITIVITY
#73Substituted pyrazolo[4,3-d]pyrimidines and imidazo[5,1 -f][1,2,4]triazines as androgen receptor and phosphodiesterase dual inhibitors
#74METHOD FOR SCREENING PERSONALIZED INTESTINAL ENVIRONMENT-IMPROVING MATERIAL AND COMPOSITION THEREFOR
#75FK506 FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
#76Real-time quantification method of cell viability through supravital dye uptake using lens-free imaging system
#77CHANNELRHODOPSINS FOR OPTICAL CONTROL OF CELLS
#78SYNTHETIC RETINOIDS FOR USE IN RAR ACTIVATION
#79USE OF PLASMA MEMBRANE PARTICLES, LIPOSOMES, AND EXOSOMES TO ASSAY IMMUNE CELL POTENCY
#80PAR2 MODULATION AND METHODS THEREOF
#81Testing Methods for Determination of T2R Phenotype and Applications Thereof
#82Screening for Inhibitors of Prostaglandin E Synthase 3 Useful for Treatment of Prostate Cancer
#83HSP90 COMBINATION THERAPY
#84IGFR-like 2 receptor and uses thereof
#85SELECTIVE GLUCOCORTICOID RECEPTOR MODIFIERS FOR TREATING IMPAIRED SKIN WOUND HEALING
#86DEVICES AND METHODS FOR SINGLE CELL ANALYSIS
#87Compounds inhibiting Nef-calnexin interaction
#88METHODS AND COMPOSITIONS FOR IMPROVED INSECT REPELLENCY
#89DETERMINING CANCER RESPONSIVENESS TO TREATMENT
#90Identification of functional cell states
#91Method of quantifying induced membrane permeability and of screening compounds able to prevent said permeability
#92NEUTRALIZING ANTIBODY ASSAY FOR THERAPEUTIC PROTEINS
#93Compositions for and Methods of Neutralizing Lipopolysaccharide Toxicity and Methods of Identifying the Same
#94Methods and pharmaceutical compositions for treating lymphoid malignancy
#95Methods and compositions related to modified green fluorescent protein (GFP) with an embedded foreign peptide
#96Wnt7 variants capable of activating g-protein coupled receptor (Gpr)124/Reck/frizzled/lipoprotein receptor-related protein (LRP)-mediated Wnt signaling
#97Method of predicting the likelihood of success of gene therapy
#98INDUCTIVE REGENERATION OF THE AIRWAY BY TRANSCRIPTIONAL FACTOR MODULATION OF GLANDULAR MYOEPITHELIAL STEM CELLS
#99INCREASING IMMUNE ACTIVITY THROUGH MODULATION OF POSTCELLULAR SIGNALING FACTORS
#100BIOSENSORS FOR DETECTING ARRESTIN SIGNALING
#101Synthetic odorant receptors
#102Method for inhibiting STAT3 activity comprising administering Ssu72
#103STEM CELL-DERIVED HUMAN MICROGLIAL CELLS, METHODS OF MAKING AND METHODS OF USE
#104E2F reporter melanoma cells
#105ABCB5 LIGANDS AND SUBSTRATES
#106METHODS AND KITS FOR IDENTIFYING A PROTEIN ASSOCIATED WITH RECEPTOR-LIGAND INTERACTIONS
#107METHOD OF MONITORING RESPONSE TO A TREATMENT
#108Multilayer stackable tissue culture platform for 3D co-culture
#109COMPOSITIONS AND METHODS THAT PROMOTE HYPOXIA OR THE HYPOXIA RESPONSE FOR TREATMENT AND PREVENTION OF MITOCHONDRIAL DYSFUNCTION AND OXIDATIVE STRESS DISORDERS
#110Selective peptide antagonists
#111Methods for immunoregulation by modulating plasminogen-apple-nematode (PAN) domain-containing proteins
#112Method for screening personalized intestinal environment-improving material and composition therefor
#113METHODS AND COMPOSITIONS FOR TREATING VITILIGO
#114Oligonucleic acid variant libraries and synthesis thereof
#115Theramutein modulators
#116SYSTEMS AND METHODS FOR CHARACTERIZING SURFACTANT PROTEIN D (SP-D) OLIGOMERS
#117Theramutein modulators
#118BIOSENSORS FOR MEASURING CELL SIGNALING IN STRESSED AND HEALTHY CELLS
#119DIGALLIC ACID FOR REDUCTION OF INFLAMMATORY CYTOKINE ACTIVITY
#120Compounds inhibiting Nef-calnexin interaction
#121ApoCIII and the Treatment and Diagnosis of Diabetes
#122Channelrhodopsins for optical control of cells
#123N-TERMINALLY TRUNCATED INTERLEUKIN-38
#124METHOD FOR SCREENING COMPOUNDS THAT MODULATE THE ACTIVITY OF THE ELECTRON TRANSPORT CHAIN
#125METHOD FOR EVALUATING EFFECT OF CYTOKINE ON METABOLIC ACTIVITY OF CYTOCHROME P450, AND DRUG SCREENING METHOD
#126CONSTRUCT FOR EXPRESSING G PROTEIN-COUPLED RECEPTOR OR SUBUNIT THEREOF, AND USE OF SAID CONSTRUCT
#127DETERMINING FUNCTIONAL STATUS OF IMMUNE CELLS TYPES AND IMMUNE RESPONSE
#128Gene-modified mouse expressing human GPC3 polypeptide
#129Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
#130Selection of agents modulating gastrointestinal pain
#131Targeting α2δ-1-bound glutamate receptors for treating diseases and disorders
#132Method for treating a chronic itch condition by administering small molecule MrgprX4 antagonists
#133COMPOSITIONS AND METHODS FOR DETECTION, RISK ASSESSMENT AND TREATMENT OF DIABETES, OBESITY, AND INFLAMMATION
#134Compositions and methods for programmable sensing and control through combinatorial molecular interactions
#135Agents that modulate immune cell activation and methods of use thereof
#136ECM COMPOSITION, TUMOR MICROENVIRONMENT PLATFORM AND METHODS THEREOF
#137AhR-ROR-γt complex as a biomarker and therapeutic target for autoimmune disease and IL-17A-associated disease
#138T1R HETERO-OLIGOMERIC TASTE RECEPTORS, CELL LINES THAT EXPRESS SAID RECEPTORS, AND TASTE COMPOUNDS
#139Theramutein modulators
#140Channelrhodopsins for optical control of cells
#141NRF2 Screening Assays and Related Methods and Compositions
#142Specific Increase of Dopamine Synthesis THrough Targeting of the Guanylate Cyclase 2C Receptor in the Treatment of Parkinson's Disease
#143Reprogramming cell aging
#144CD147 AS RECEPTOR FOR PILUS-MEDIATED ADHESION OF MENINGOCOCCI TO VASCULAR ENDOTHELIA
#145ECM COMPOSITION, TUMOR MICROENVIRONMENT PLATFORM AND METHODS THEREOF
#146ECM COMPOSITION, TUMOR MICROENVIRONMENT PLATFORM AND METHODS THEREOF
#147Systems and methods for detecting bioactive compounds using sensors with pre-stimulated cells
#148Method for treating a pathological condition involving the activation or proliferation of CD127 positive cells with an anti-CD127 antibody
#149PHARMACEUTICAL COMBINATIONS FOR IMMUNOTHERAPY
#150Bioassay for insulin formulations
#151CHIMERIC RECEPTORS, BIOSENSOR HOST CELLS AND METHODS/USES THEREOF
#152CD2-associated protein (CD2AP) and its interactive proteins
#153ECM COMPOSITION, TUMOR MICROENVIRONMENT PLATFORM AND METHODS THEREOF
#154NOVEL IGFR_LIKE 2 RECEPTOR AND USES THEREOF
#155Channelrhodopsins for optical control of cells
#156METHOD FOR PROMOTING WOUND HEALING BY ADMINISTERING A COMPOUND WHICH BINDS LDL-RECEPTOR-RELATED PROTEIN (LRP) LIGAND BINDING DOMAIN
#157ECM COMPOSITION, TUMOR MICROENVIRONMENT PLATFORM AND METHODS THEREOF
#158METHOD FOR PREPARING TOPOGRAPHICALLY STRUCTURED MICROARRAYS
#159Opioid receptor binding agents and uses thereof
#160Autophagy enhancer and use thereof
#161DISEASE PATHWAY-BASED METHOD TO GENERATE BIOMARKER PANELS TAILORED TO SPECIFIC THERAPEUTICS FOR INDIVIDUALIZED TREATMENTS
#162CXR4 as a susceptibility locus in juvenile idiopathic arthritis (JIA) and methods of use thereof for the treatment and diagnosis of the same
#163Non-alcoholic fatty liver regulator 14-3-3 protein
#164METHODS FOR IDENTIFYING MODULATORS OF MEMBRANE POTENTIALS IN BIPOLAR DISORDER AND ATTENTION DEFICIT HYPERACTIVITY DISORDER
#165ANTI-METHANOGENIC COMPOSITIONS
#166CREBBP RELATED CANCER THERAPY
#167METHODS AND KITS FOR ANALYSING THE STEADY-STATE ACTIVATION OR INHIBITION OF ITAM SIGNALLING OF IMMUNORECEPTORS IN BLOOD LEUKOCYTES
#168GPCR (GPR113) INVOLVED IN FAT, FATTY ACID AND/OR LIPID-ASSOCIATED TASTE AND USE IN ASSAYS FOR IDENTIFYING TASTE MODULATORY
#169Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
#170Drug target for preventing pathologic calcium overload in cardiomyocytes and methods of screening for same
#171METHOD FOR PREDICTING THE RESPONSE TO HER2-DIRECTED THERAPY
#172Methods of using T1R hetero-oligomeric taste receptors to screen for compounds which modulate sweet or umami taste signaling
#173Methods and Pharmaceutical Compositions for Treating Lymphoid Malignancy
#174Methods for the Characterisation of Interaction Sites on Target Proteins
#175Generation of brown adipose tissue from pluripotent stem cells in vitro
#176Method of measuring cell-substrate impedance in living cells to identify compounds affecting receptor tyrosine kinase (RTK) activity and pathways for the treatment of cancer
#177COMPOSITIONS FOR DIAGNOSIS AND THERAPY OF DISEASES ASSOCIATED WITH ABERRANT EXPRESSION OF FUTRINS (R-SPONDINS) AND/OR WNT
#178Screening assay for choice of prebiotic to prevent/treat gastrointestinal and systemic diseases
#179Therapeutic intervention for osteoporosis
#180COMPOUNDS USEFUL FOR DECREASING INTERFERON LEVEL
#181GENE-MODIFIED NON-HUMAN ANIMAL EXPRESSING HUMAN GPC3 POLYPEPTIDE
#182ECM COMPOSITION, TUMOR MICROENVIRONMENT PLATFORM AND METHODS THEREOF
#183Genetically encoded calcium indicators and methods of use
#184PPAR AGONIST OR LXR AGONIST FOR USE IN THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS BY MODULATION OF LAP ACTIVITY
#185Modified multispanning membrane polypeptides and methods of use thereof to screen therapeutic agents
#186METHODS AND COMPOSITIONS FOR NICOTINIC RECEPTOR ASSAYS
#187Method and system for cell collection based on information regarding change over time
#188USE OF FK506 FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
#189In vitro methods of detecting heteroligomeric T1R2/T2R3-expressing cells that are potentially sensitive to sweet tastants
#190METHODS FOR DIAGNOSIS AND TREATMENT OF SOLAR LENTIGO
#191Compounds inhibiting Nef-calnexin interaction
#192Methods of identifying modulators of CASTOR1-GATOR2 interaction and use of same to modulate mTORC1
#193Methods of measuring signaling pathway activity for selection of therapeutic agents
#194NUCLEIC ACIDS ENCODING A G-PROTEIN COUPLED RECEPTOR INVOLVED IN SENSORY TRANSDUCTION
#195Compositions and methods that promote hypoxia or the hypoxia response for treatment and prevention of mitochondrial dysfunction and oxidative stress disorders
#196Calcium indicator polypeptides and methods of use thereof
#197Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
#198Selective peptide antagonists
#199ApoCIII and the Treatment and Diagnosis of Diabetes
#200Transformed cell lines expressing non-endogenous cell-surface selective guanosine-responsive G-protein coupled receptors
#201A Method of Screening for Modulation of Cell Signalling Pathways
#202Method for inhibiting or masking fishy odours
#203Host cells and systems for membrane protein expression
#204Genetically encoded calcium indicators and methods of use
#205Antigens and T cell epitopes from cockroach and methods of making and using same
#206BARCODED RAPID ASSAY PLATFORM USEFUL FOR EFFICIENT ANALYSIS OF CANDIDATE MOLECULES AND METHODS OF MAKING AND USING THE PLATFORM
#207Complement split product C4d for the treatment of inflammatory conditions
#208NRF2 Screening Assays and Related Methods and Compositions
#209Selection of agents modulating gastrointestinal pain
#210SCREENING ASSAY TO IDENTIFY IDO1 AND/OR TDO MODULATORS
#211Tools and methods for expression of membrane proteins
#212Detection of oral microbial virulence factors
#213MECHANISM AND DRUG TARGETS FOR REDUCING CELL EDEMA (NEUROPROTECTION) AND CYTOPLASMIC EXCITABILITY IN ASTROCYTES IN NORMAL AND PATHOLOGICAL STATES
#214Novel Cell Based Assay
#215Non-alcoholic fatty liver regulator 14-3-3 protein
#216REGULATORS OF NFAT
#217USE OF FK506 FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
#218Activators of TonEBP for use for hydrating skin
#219CELL LINES MUTANT FOR PATCHED 1 AND PATCHED 2 AND METHODS OF USE THEREOF
#220E2F REPORTER MELANOMA CELLS
#221METHODS FOR TREATMENT OF CARDIOVASCULAR DISEASE
#222Methods for Treatment with Bucindolol Based on Genetic Targeting
#223MODELS, METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY BOWEL DISEASE
#224Method of preventing rheumatoid arthritis comprising administering polynucleotide encoding SSU72
#225METHODS FOR GENERATING ENDOGENOUSLY TAGGED PROTEINS
#226METHOD FOR IDENTIFYING COMPOUNDS THAT MODULATE A T2R TASTE RECEPTOR
#227Cell information acquisition method and cell information acquisition device
#228ENTERICALLY DELIVERED BITTER OLIGOPEPTIDES FOR THE TREATMENT FOR TYPE 2 DIABETES
#229USE OF ENDOGENOUS PROMOTERS TO EXPRESS HETEROLOGOUS PROTEINS
#230T1R taste receptors and genes encoding same
#231TREATMENT OF DIABETES USING AGONISTS OF THE MAS-RELATED GPCR D
#232Methods for labeling and manipulating a cellular circuit
#233Universal antibody-mediated biosensor
#234Methods And Compositions For Modifying Sensorial Perception
#235Mutant smoothened and methods of using the same
#236Theramutein modulators
#237METHOD FOR PREDICTING THE RESPONSE TO HER2-DIRECTED THERAPY
#238METHOD OF BLOCKING PERCEPTION OF MALODOR
#239T1R hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds
#240Method of measuring cell-substrate impedance in living cells to identify compounds affecting receptor tyrosine kinase (RTK) activity and pathways
#241Methods of detecting T1R hetero-oligomeric taste receptor expression to identify cells that are potentially sensitive to sweet tastants
#242MUTANT NQ-RHODOPSIN KR 2
#243METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING PRURITIS
#244Methods for treating and/or limiting development of diabetes
#245EXPRESSION AND FUNCTION OF GPR64/ADGRG2 IN ENDOCRINE SYSTEMS AND METHODS TO TARGET IT THERAPEUTICALLY
#246NOVEL TISSUE PROTECTIVE ERYTHROPOIETIN RECEPTOR (NEPOR) AND METHODS OF USE
#247Agonists of the mu opioid receptor
#248METHODS AND COMPOSITIONS FOR SYSTEMIC LUPUS ERYTHEMATOSUS
#249SYSTEMS AND METHODS FOR ASSESSING INTER-CELL COMMUNICATION
#250METHODS FOR DIAGNOSIS, PROGNOSIS AND METHODS OF TREATMENT
#251Genetically encoded calcium indicators and methods of use
#252Methods of Treatment
#253Methods of identifying modulators of sestrin-gator-2 interaction for modulating mTORC1 activity
#254Methods for identifying a receptor for a ligand and uses thereof
#255ANALYSIS OF CELL NETWORKS
#256Screening methods for thyroid hormone disruptors based on co-regulator involved simulations
#257Feline bitter taste receptors and methods
#258Using impedance-based cell response profiling to identify putative inhibitors for oncogene addicted targets or pathways
#259METHODS FOR DIAGNOSIS, PROGNOSIS AND METHODS OF TREATMENT
#260Methods and Pharmaceutical Compositions for Treating Lymphoid Malignancy
#261METHODS FOR IDENTIFYING COMPOUNDS THAT ALTER THE ACTIVITY OF IRHOM POLYPEPTIDES AND USE THEREOF
#262High-throughput screening for compounds modulating expression of cellular macromolecules
#263Composition and methods for modulation of the octopamine receptor and its homologs
#264Methods of using TIR hetero-oligomeric receptors for screening compounds that modulate sweet or umami taste
#265N-terminally truncated interleukin-38
#266Prophylactic agent and therapeutic agent for fibrodysplasia ossificans progressiva
#267Method for analyzing activation state of signaling pathway and method for selecting personalized medicine using same
#268Compositions and methods for regulating glucose metabolism
#269Genetically encoded fluorescent sensors for detecting intracellular signalling through diacylglycerol pathways
#270Feline bitter taste receptors and methods
#271Compositions and methods for identifying protease inhibitors
#272PHARMACEUTICAL COMBINATIONS FOR IMMUNOTHERAPY
#273Screening assay for choice of prebiotic to prevent/treat gastrointestinal and systemic diseases
#274Opioid receptor binding agents and uses thereof
#275STING AGONISTS AND METHODS OF SELECTING STING AGONISTS
#276ApoIII and the treatment and diagnosis of diabetes
#277Antibodies directed against CD127
#278Detoxification of microbial virulence factors in oral cavity
#279G-protein-coupled-receptor-22-transformed cell lines and methods of use thereof to identify binding compounds
#280SPECIFIC MODULATORS OF CONNEXIN HEMICHANNELS
#281Theramutein modulators
#282Sperm-Specific Cation Channel, and Uses Therefor
#283METHODS FOR DETERMINING THE EFFECTS OF COMPOUNDS ON JAK/STAT ACTIVITY
#284Process for making modulators of cystic fibrosis transmembrane conductance regulator
#285Channelrhodopsins for optical control of cells
#286Methods for Inhibiting Epithelial to Mesenchymal Transition by Inhibition of FOXS1
#287Oligonucleic acid variant libraries and synthesis thereof
#288Methods for determining susceptibility to coreceptor inhibitors
#289DISEASE PATHWAY-BASED METHOD TO GENERATE BIOMARKER PANELS TAILORED TO SPECIFIC THERAPEUTICS FOR INDIVIDUALIZED TREATMENTS
#290Methods and compositions for targeting cancer stem cells
#291Methods for identifying modulators of membrane potentials in bipolar disorder and attention deficit hyperactivity disorder
#292USE OF FK506 FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
#293Methods for determining modulators of insect transient receptor potential V (TRPV) channel
#294Cold- and menthol-sensitive receptor (CMR1)
#295Identification of functional cell states
#296CXCR4 as a susceptibility locus in juvenile idiopathic arthritis (JIA) and methods of use thereof for the treatment and diagnosis of the same
#297Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
#298Selection of Agents Modulating Gastrointestinal Pain
#299OPTICALLY ACTIVATED RECEPTORS
#300Methods of identifying modulators of olfactory receptors